By the end of the week, drug maker Johnson and Johnson is expected submit its COVID-19 vaccine to the FDA for emergency use authorization.
By the end of the week, drug maker Johnson and Johnson is expected submit its COVID-19 vaccine to the FDA for emergency use authorization.